Hôpital Ambroise-Paré

Boulogne-Billancourt, Île-de-France Region 92100

2 studies enrolling now · 4 studies all time

What they study most

Adjuvant, Advanced Non-Small Cell Lung Cancer, Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), EGFR, Early Stage Lung Cancer, Exon 20, Lung Cancer, Metastatic Non Small Cell Lung Cancer, NSCLC, Stage IB-IIIA, Non-Small Cell Lung Cancer

Studies at this site

• Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Recruiting now
• Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer — Recruiting now
• REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) — Running, not enrolling
• A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection — Running, not enrolling